Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 79Bayer AG
02 5Abacus Medicine
03 5MSN Laboratories
04 5Sandoz B2B
05 4Teva Pharmaceutical Industries
01 38Film Coated Tablet
02 5Film-Coated Tablet
03 2Granule For Oral Suspension
04 1Riociguat 0.5Mg 42 Combined Oral Use
05 1Riociguat 1,5Mg 42 Combined Oral Use
06 1Riociguat 1,5Mg 84 Combined Oral Use
07 1Riociguat 1Mg 42 Combined Oral Use
08 1Riociguat 1Mg 84 Combined Oral Use
09 1Riociguat 2,5Mg 42 Combined Oral Use
10 1Riociguat 2,5Mg 84 Combined Oral Use
11 1Riociguat 2Mg 42 Combined Oral Use
12 1Riociguat 2Mg 84 Combined Oral Use
13 10TABLET
14 14TABLET;ORAL
15 20Blank
01 5Allowed
02 6Approved
03 9Authorized
04 13Marketed
05 1Not Marketed
06 10PRESCRIPTION
07 11Prescription
08 10RX
09 33Blank
01 10ADEMPAS
02 74Adempas
03 9RIOCIGUAT
04 5SANDOZ RIOCIGUAT
01 20Australia
02 10Canada
03 5Denmark
04 6Estonia
05 9Italy
06 14Norway
07 9Spain
08 6Sweden
09 5Switzerland
10 14USA
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : RX
Registration Country : USA
Brand Name : ADEMPAS
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2013-10-08
Application Number : 204819
Regulatory Info : RX
Registration Country : USA
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : RX
Registration Country : USA
Brand Name : ADEMPAS
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2013-10-08
Application Number : 204819
Regulatory Info : RX
Registration Country : USA
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : RX
Registration Country : USA
Brand Name : ADEMPAS
Dosage Form : TABLET;ORAL
Dosage Strength : 1.5MG
Packaging :
Approval Date : 2013-10-08
Application Number : 204819
Regulatory Info : RX
Registration Country : USA
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : RX
Registration Country : USA
Brand Name : ADEMPAS
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2013-10-08
Application Number : 204819
Regulatory Info : RX
Registration Country : USA
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : RX
Registration Country : USA
Brand Name : ADEMPAS
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2013-10-08
Application Number : 204819
Regulatory Info : RX
Registration Country : USA
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 0.5Mg 42 Combined Oral Use
Dosage Strength : 42 cpr riv 0.5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 1Mg 42 Combined Oral Use
Dosage Strength : 42 cpr riv 1 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 1Mg 84 Combined Oral Use
Dosage Strength : 84 cpr riv 1 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 1,5Mg 42 Combined Oral Use
Dosage Strength : 42 cpr riv 1.5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 1,5Mg 84 Combined Oral Use
Dosage Strength : 84 cpr riv 1.5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 2Mg 42 Combined Oral Use
Dosage Strength : 42 cpr riv 2 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 2Mg 84 Combined Oral Use
Dosage Strength : 84 cpr riv 2 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 2,5Mg 42 Combined Oral Use
Dosage Strength : 42 cpr riv 2.5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info :
Registration Country : Italy
Brand Name : Adempas
Dosage Form : Riociguat 2,5Mg 84 Combined Oral Use
Dosage Strength : 84 cpr riv 2.5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Adempas
Dosage Form : Film Coated Tablet
Dosage Strength : 0.5mg
Packaging :
Approval Date : 21/11/2013
Application Number : 62903
Regulatory Info : Allowed
Registration Country : Switzerland
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Adempas
Dosage Form : Film Coated Tablet
Dosage Strength : 1mg
Packaging :
Approval Date : 21/11/2013
Application Number : 62903
Regulatory Info : Allowed
Registration Country : Switzerland
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Adempas
Dosage Form : Film Coated Tablet
Dosage Strength : 1.5mg
Packaging :
Approval Date : 21/11/2013
Application Number : 62903
Regulatory Info : Allowed
Registration Country : Switzerland
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Adempas
Dosage Form : Film Coated Tablet
Dosage Strength : 2mg
Packaging :
Approval Date : 21/11/2013
Application Number : 62903
Regulatory Info : Allowed
Registration Country : Switzerland
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Adempas
Dosage Form : Film Coated Tablet
Dosage Strength : 2.5mg
Packaging :
Approval Date : 21/11/2013
Application Number : 62903
Regulatory Info : Allowed
Registration Country : Switzerland
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Adempas
Dosage Form : Film Coated Tablet
Dosage Strength : 0.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
